| Primary |
| Cerebrovascular Accident Prophylaxis |
100.0% |
|
| Blood Creatinine Increased |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
70.6% |
| Atherosclerosis Prophylaxis |
5.9% |
| Blood Cholesterol |
5.9% |
| Headache |
5.9% |
| High Density Lipoprotein Abnormal |
5.9% |
| High Density Lipoprotein Decreased |
5.9% |
|
| Abdominal Pain Upper |
50.0% |
| Pruritus |
50.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
53.4% |
| Drug Use For Unknown Indication |
23.0% |
| Hypertension |
2.2% |
| Osteoporosis |
2.2% |
| Pain |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Diabetes Mellitus |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| High Density Lipoprotein Decreased |
1.4% |
| Blood Triglycerides Increased |
1.2% |
| Cardiac Disorder |
1.2% |
| Blood Cholesterol |
1.1% |
| Glaucoma |
0.9% |
| Insomnia |
0.9% |
| Major Depression |
0.8% |
| Thrombosis Prophylaxis |
0.8% |
| Atrial Fibrillation |
0.7% |
| Behcet's Syndrome |
0.6% |
| Depression |
0.6% |
|
| Vomiting |
19.8% |
| Weight Decreased |
10.9% |
| Visual Acuity Reduced |
7.9% |
| Pruritus |
6.9% |
| Wrist Fracture |
5.9% |
| Flushing |
5.0% |
| Vision Blurred |
5.0% |
| Myocardial Infarction |
4.0% |
| Pulmonary Oedema |
4.0% |
| Cardiac Failure |
3.0% |
| Dyspnoea |
3.0% |
| Hyperhidrosis |
3.0% |
| Pancreatitis |
3.0% |
| Perivascular Dermatitis |
3.0% |
| Prostatic Specific Antigen Increased |
3.0% |
| Skin Laceration |
3.0% |
| Thrombosis |
3.0% |
| Unresponsive To Stimuli |
3.0% |
| Blood Pressure Increased |
2.0% |
| Drug Dose Omission |
2.0% |
|
